AR126954A1 - Métodos para tratar la psoriasis con uno o más antagonistas de receptores de cgrp - Google Patents
Métodos para tratar la psoriasis con uno o más antagonistas de receptores de cgrpInfo
- Publication number
- AR126954A1 AR126954A1 ARP220102366A ARP220102366A AR126954A1 AR 126954 A1 AR126954 A1 AR 126954A1 AR P220102366 A ARP220102366 A AR P220102366A AR P220102366 A ARP220102366 A AR P220102366A AR 126954 A1 AR126954 A1 AR 126954A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- receptor antagonists
- cgrp receptor
- treating psoriasis
- snhc
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- 108010078311 Calcitonin Gene-Related Peptide Receptors Proteins 0.000 title abstract 3
- 102000008323 calcitonin gene-related peptide receptor activity proteins Human genes 0.000 title abstract 3
- 239000002464 receptor antagonist Substances 0.000 title abstract 3
- 229940044551 receptor antagonist Drugs 0.000 title abstract 3
- 101100294106 Caenorhabditis elegans nhr-3 gene Proteins 0.000 abstract 1
- 101100203601 Caenorhabditis elegans sor-3 gene Proteins 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240064P | 2021-09-02 | 2021-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR126954A1 true AR126954A1 (es) | 2023-12-06 |
Family
ID=85412863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220102366A AR126954A1 (es) | 2021-09-02 | 2022-09-01 | Métodos para tratar la psoriasis con uno o más antagonistas de receptores de cgrp |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR126954A1 (fr) |
| WO (1) | WO2023034466A1 (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220862B2 (en) * | 2002-06-05 | 2007-05-22 | Bristol-Myers Squibb Company | Calcitonin gene related peptide receptor antagonists |
| DE60326370D1 (de) * | 2002-08-12 | 2009-04-09 | Actavis Group Hf | Verwendung von cgrp-antagonisten-verbindungen zur behandlung von psoriasis |
| JP2007524568A (ja) * | 2003-12-05 | 2007-08-30 | ブリストル−マイヤーズ スクイブ カンパニー | カルシトニン遺伝子関連ペプチドレセプターアンタゴニスト |
| SI2820016T1 (sl) * | 2012-02-27 | 2017-11-30 | Bristol-Myers Squibb Company | N-(5s,6s,9r)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5h- ciklohepta (b)piridin-9-il-4-(2-okso-2, 3-dihidro-1h-imidazo(4,5-b) piridin-1-il) piperidin-1-karboksilat, hemisulfatna sol |
| GB201519196D0 (en) * | 2015-10-30 | 2015-12-16 | Heptares Therapeutics Ltd | CGRP Receptor Antagonists |
| AU2020210024A1 (en) * | 2019-01-20 | 2021-07-01 | Biohaven Pharmaceutical Holding Company Ltd. | CGRP antagonists for treating migraine breakthrough |
-
2022
- 2022-09-01 AR ARP220102366A patent/AR126954A1/es unknown
- 2022-09-01 WO PCT/US2022/042282 patent/WO2023034466A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023034466A1 (fr) | 2023-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR115885A1 (es) | Compuestos derivados de 1h-pirazolo[4,3-d]pirimidina como agonistas del receptor 7 tipo toll (tlr7) y su uso en combinación con un agente de inmunoterapia anticancerígeno | |
| AR110782A1 (es) | Derivados de tirosinamida como inhibidores de rho-quinasa | |
| AR109788A1 (es) | Compuestos de benzo[b]tiofeno como agonistas de sting | |
| AR110400A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer | |
| AR010067A1 (es) | Heterociclos de 5 anillos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4 | |
| AR112098A1 (es) | 3-fenilisoxazolin-5-carboxamidas de tetrahidro- y dihidrofurancarboxamida con efecto herbicida | |
| AR010065A1 (es) | COMPUESTOS HETEROCíCLICOS Y EL USO DE LOS MISMOS PARA LA PREPARACION DE FARMACOS UTILES COMO INHIBIDORES DE LA ADHESION DE LEUCOCITOS Y ANTAGONISTAS DE LA VLA-4 | |
| AR099367A1 (es) | Inhibidores de la tirosina quinasa de bruton | |
| ES179305A1 (es) | UN PROCEDIMIENTO PARA PREPARAR POLISILOXANOS LiQUIDOS | |
| ECSP19029835A (es) | Compuestos del péptido tirosina tirosina cíclico como moduladores de receptores de neuropéptido y | |
| AR114828A1 (es) | Compuestos de pteridinona y sus usos | |
| AR095279A1 (es) | N-(4-(azaindazol-6-il)-fenil)-sulfonamidas y su uso como productos farmacéuticos | |
| PE20180119A1 (es) | Sulfonas triciclicas como moduladores del receptor huerfano relacionado con retinoide gamma (rorgamma) | |
| AR092670A1 (es) | Derivados de quinazolinona | |
| AR099937A1 (es) | Compuestos de isoindolinona como moduladores de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados | |
| AR120823A1 (es) | Compuestos bicíclicos sustituidos útiles como activadores de células t | |
| AR094553A1 (es) | Formas de oxadiazolpirazina | |
| AR103232A1 (es) | ANTAGONISTAS DE TGFbR | |
| AR114369A1 (es) | Dinucleótidos cíclicos como agentes antineoplásicos | |
| AR069513A1 (es) | Derivados de amidas del acido 6,7-dihidro -5h-imidazo¿1,2-alfa]imidazol-3-carboxilico, y composiciones farmaceuticas que los contienen | |
| AR113790A1 (es) | Amidas de imidazopiridina sustituidas y su uso | |
| AR111494A1 (es) | Compuestos de anilinoquinazolina c₅ y su uso en el tratamiento del cáncer | |
| CR20170371A (es) | Compuestos de benzoxaboral 4-sustituidos y uso de los mismos | |
| AR126954A1 (es) | Métodos para tratar la psoriasis con uno o más antagonistas de receptores de cgrp | |
| AR114496A1 (es) | Compuestos antiproliferación y usos de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |